Item 2.05 Costs Associated with Exit or Disposal Activities.
On June 18, 2007, Molex Incorporated ("Molex") filed a current report on Form 8-K regarding its multi-year plan to implement restructuring initiatives designed to reduce costs and improve return on invested capital in connection with the new global organization launched on July 1, 2007. At that time, Molex was unable to make a determination of the estimated amount or ranges of amounts to be incurred for each major type of cost and the charges and future cash expenditures associated therewith. Molex is filing this Form 8-K/A to amend the June 18, 2007 Form 8-K to update the disclosure therein.
Molex expects to incur total restructuring and asset impairment costs related to the restructuring of approximately $280 million.
The $280 million restructuring and asset impairment costs related to the restructuring includes the following: $220 - 225 million for employee termination benefit costs; $7 - 8 million pension curtailment gain; and $60 - 65 million for manufacturing asset impairments or write-offs.
Molex estimates that approximately all of the remaining estimated restructuring charge of $26 million will be recorded in fiscal year 2010. The restructuring is expected to result in total cash expenditures of approximately $220 - 225 million.
Molex's analysis is subject to change and the timing of the implementation of these initiatives and the resulting charges and cash expenditures will be dependent upon a number of factors. If there are further exit and disposal costs in addition to the $280 million, Molex will file an amendment to this report once it is able to make good faith determinations of the estimated costs and future cash expenditures associated with its restructuring initiatives.
Cautionary Note Regarding Forward-Looking Statements Statements in this Form 8-K that are not historical, including statements regarding Molex's restructuring initiatives, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on currently available information and are subject to various risks and uncertainties that could cause actual results to vary materially from those stated. These risks and uncertainties are set forth in Molex's documents filed with the Securities and Exchange Commission, including Item 1A of its Form 10-K for the year ended June 30, 2009. This report speaks only as of its date and, except to the extent required by law, Molex disclaims any obligation to revise these forward-looking statements or to provide any updates regarding information contained in this release resulting from new information, future events or otherwise.

---